News

Zealand Pharma appoints Utpal Singh as CSO
Zealand Pharma (ZLDPF) announces the appointment of Utpal Singh as Chief Scientific Officer. Utpal will join the executive team to lead ...
Zealand Pharma launches long-term incentive programs for board of directors
Zealand Pharma (ZLDPF) announces the implementation of long-term incentive programs for 2025 for Zealand Pharma’s Board of Directors, Corporate ...
SA Asks: What's the best weight-loss drug stock right now?
Seeking Alpha analyst Stephen Ayers shares his views on which weight-loss drug stock looks most attractive for investors ...
Nasdaq17d
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?
Another stock from the same industry, Zealand Pharma A/S ZLDPF, closed the last trading session 5% lower at $58.87. Over the past month, ZLDPF has returned -19.6%. For Zealand Pharma AS ...
Investing18d
Novo Nordisk A/S Class B (NOVOb)
Danish biotechnology research company Zealand Pharma A/S (CSE:ZELA) (ZLDPF) saw its shares soar more than 35% in Copenhagen on... Investing.com -- Equity market growth is in position to broaden ...
The Globe and Mail1mon
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vicarious Surgical (RBOT), Alkermes (ALKS) and Zealand Pharma (OtherZLDPF)
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Vicarious Surgical. The company’s shares closed last Monday at $9.63. According to TipRanks.com, Zimmerman is ...